Investing Profile

Denis Patrick

InvestorVC
Vice President at Pfizer
pfizer.comNew York
Photo of Denis Patrick, Pfizer Venture Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Pfizer Network
16 CONNECTIONS
Pfizer Network
16 CONNECTIONS
Merck Network
14 CONNECTIONS
cb
$100K - $15.0M
$10.0M
7
CompanyStageDateRound SizeTotal Raised
FoRx Therapeutics
Series AJun 2025$49M
SeedApr 2020$11M
$60M
Co-investors: Vincent Ossipow (Omega Funds)
MISSION Therapeutics
Series DMar 2024$32M
Series CJul 2020$15M
Series CFeb 2016$86M
Series BNov 2013$32M
$170M
Co-investors: Graziano Seghezzi (Soffinova Partners), Deborah Harland (SR One)
Anaveon
Series BDec 2021$120M
$120M
Co-investors: Jasper Bos (Forbion), Ohad Hammer (Pontifax Venture Capital)
Board Member EvolveImmune Therapeutics2020 - Present
Board Member Mission Therapeutics2019 - Present
Board Member eFFECTOR Therapeutics, Inc.2019 - Present
Vice President Pfizer2018 - Present
Executive Director, Head, External R&D Innovation, Oncology Research Unit Pfizer2010 - Present
Board Member FoRx Therapeutics2019 - 2020
Director, Oncology Scientific Licensing, Business Development GlaxoSmithKline2002 - 2010
Director, Oncology Biology R&D GlaxoSmithKline2002 - 2007
Associate Director DuPont Pharmaceuticals1999 - 2001
Research Fellow Merck1988 - 1999